Respiratory News and Research

RSS

Routine pediatric lung therapies do not improve ventilator-free days

Results from the largest international clinical trial of its kind show that early, routine use of prone positioning and/or high-frequency oscillatory ventilation (HFOV) do not increase ventilator-free days for children with pediatric acute respiratory distress syndrome (PARDS).

6 Nov 2026

China's stricter air quality standards can avert over 200,000 deaths

China introduced a 35 µg m⁻³ annual PM₂.₅ limit in 2012 and later cut population-weighted exposure from 62.8 to 29.7 µg m⁻³ between 2013 and 2024 through clean air actions.

6 Nov 2026

Medical societies unify to endorse evidence-based respiratory vaccine guidance

Hoping to provide much-needed guidance to clinicians treating patients with lung disease and to promote respiratory health, the Vaccine Guidance Review Panel, a multi-medical society effort, announced its endorsement of influenza, RSV and COVID-19 recommendations for adults and children.

5 Nov 2026

AI-designed vaccine provides complete protection against diverse bird flu variants

A University of Cambridge team has had a third success with their AI-guided technique for designing vaccines against highly infectious viruses that threaten animal and human health.

5 Nov 2026

Graded physical activity prescriptions improve functional outcomes in psychiatry

Most of us have heard the advice so often that it has worn smooth, like a stone in a river: get some exercise. A new peer-reviewed Viewpoint in Brain Health, drawing on randomized trials, meta-analyses, and cohort studies, argues that this familiar sentence has been doing the wrong job.

5 Nov 2026

Exercise may improve mood and memory, and researchers say doctors should prescribe it

In a Viewpoint, researchers examined evidence that exercise can reduce symptoms of depression and anxiety, support cognition, and may help lower the risk of cognitive decline, although evidence for dementia prevention remains largely observational. The authors argue that exercise should be prescribed as a structured component of brain-health care, with individualized recommendations that account for medical conditions, safety, and barriers to participation.

4 Nov 2026

New method detects lung antibodies through non-invasive exhaled breath

For the first time, researchers have succesfully measured antibodies against specific respiratory viruses in exhaled air. This is shown in a new study involving, amongst others, the Karolinska Institutet, published in eBioMedicine.

4 Nov 2026

Comprehensive genetic map offers new hope for tuberculosis treatments

Rockefeller scientists have created the most comprehensive map to date of how essential genes interact in Mycobacterium tuberculosis (Mtb), the bacterium responsible for tuberculosis (TB).

4 Nov 2026

Pulse oximeter bias undercounts sleep apnea severity in Black patients

Sleep studies often use a pulse oximeter to determine the severity of sleep apnea. But a new study by investigators from Mass General Brigham reports that pulse oximeters may undercount breathing events in Black patients, potentially leading to inaccurate severity classifications.

4 Nov 2026

Novel treatment clears dementia-linked proteins from the waking brain

The brain's own clearance mechanisms are most active during sleep. Researchers have now shown that this natural clearance process can also be enhanced while people are awake.

4 Nov 2026

Study identifies new target to improve ulcerative colitis treatments

Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease in which persistent mucosal inflammation damages the epithelial barrier.

3 Nov 2026

New initiative provides lung cancer screening for Illinois firefighters

Northwestern Medicine will screen more than 300 firefighters from Chicago and DeKalb, Illinois, for lung cancer through its innovative Lung Health Center at the Canning Thoracic Institute, continuing efforts to detect cancer earlier in populations at increased risk.

3 Nov 2026

1nhaler secures £2.2 million to continue late-stage development

The 1nhaler, a Scotland-based drug delivery device developer, has secured £2.2 million in follow-on funding to progress its novel pop-up cardboard inhaler towards first regulatory approval.

3 Nov 2026

New age-specific prediction models improve incomplete Kawasaki disease diagnosis

Incomplete Kawasaki disease (IKD) remains hard to recognize because it often lacks the classic signs of complete Kawasaki disease (CKD), yet delayed diagnosis can lead to coronary artery damage.

2 Nov 2026

Targeting EGFR signaling to reduce mucus overproduction in lung diseases

Airway mucus is part of innate lung defense, but when production overwhelms clearance, it obstructs airflow and worsens disease.

2 Nov 2026

Qureight publishes in the European Respiratory Journal, calling for fibrosis burden to become the principal structural imaging biomarker for antifibrotic trials

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, today announced the publication of a peer-reviewed Viewpoint in the European Respiratory Journal (ERJ).

From Qureight 2 Nov 2026

Extreme heat and cold hit some people far harder, and it's not just about illness

Researchers analysing 285,444 adults in Finland and the UK found that excess mortality associated with extreme heat and cold was more than tenfold higher among people with both pre-existing medical conditions and socioeconomic disadvantage than among those with neither or only one vulnerability. Climate modelling suggested that warming from approximately 1°C to 4°C could increase the proportion of deaths attributable to extreme temperatures from around 1% to more than 5% in both countries.

1 Nov 2026

FDA approves ILUMYA for adults with active psoriatic arthritis

Sun Pharmaceutical Industries Limited announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ILUMYA® (tildrakizumab-asmn) for the treatment of adults with active psoriatic arthritis (PsA).

30 Oct 2026

Mayo Clinic enters new medical era with precure research

Mayo Clinic researchers are uncovering the earliest shifts in disease biology - long before symptoms appear - revealing how disease takes root and opening new possibilities to identify, predict and potentially prevent disease before symptoms develop.

30 Oct 2026

Bedfont® Scientific strengthens its commitment to respiratory clinical research

Bedfont® Scientific Limited, a world leader in breath analysis with 50 years of experience manufacturing medical devices, has quietly supported respiratory research around the world and is set to make its debut at its first clinical trial-focused event in November, taking the next step toward a dedicated focus on supporting clinical trials and clinical research teams, marking the beginning of a new chapter at Bedfont®.

From NObreath 29 Oct 2026